Avalon Trust’s HCA Healthcare HCA Stock Holding History

Avalon Trust’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	-$1.28K	–	528
2025 Q3	$1.28K	Buy	+3	New	+$1.16K	﹤0.01%	488

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Avalon Trust's HCA Position: Q4 2025 in Review

Avalon Trust sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 3 shares — an estimated $1.28K sold.

Avalon Trust first reported a position in HCA in Q3 2025 and held it in 1 quarter. The position peaked at $1.28K in Q3 2025. 1,399 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

Avalon Trust reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
Avalon Trust sold 3 HCA Healthcare shares in Q4 2025, an estimated $1.28K.
Avalon Trust first reported a position in HCA Healthcare in Q3 2025 and held it in 1 quarter.
Avalon Trust's HCA Healthcare position peaked at $1.28K in Q3 2025.
1,399 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.